Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Dreyling

Showing results (31-40 of 336) with videos related to

Pageof 34
Sort By:
Hematological Oncology|June 9, 2021
Mantle cell lymphoma-Advances in molecular biology, prognostication and treatment approachesElisabeth Silkenstedt, Martin Dreyling
Haematologica|February 3, 2016
The role of targeted treatment in mantle cell lymphoma: is transplant dead or alive?Martin Dreyling, Simone Ferrero,
Leukemia & Lymphoma|February 13, 2010
Rituximab in relapsed aggressive lymphoma: play it again, Sam?Martin Dreyling, Christian Schmidt
Drugs|April 8, 2016
The Emerging Role of PI3K Inhibitors in the Treatment of Hematological Malignancies: Preclinical Data and Clinical Progress to DateTill Seiler, Grit Hutter, Martin Dreyling
Cancer Treatment Reviews|June 27, 2017
Mantle cell lymphoma - Current standards of care and future directionsPeter Martin, Paola Ghione, Martin Dreyling
The Lancet. Haematology|December 6, 2016
Time to publish: challenging the performance of cooperative group lymphoma trialsMassimo Federico, Judith Trotman, Martin Dreyling
Cancer|August 27, 2004
The role of fludarabine in the treatment of follicular and mantle cell lymphomaGeorg Lenz, Wolfgang Hiddemann, Martin Dreyling
Hemasphere|March 27, 2023
La Cantera: "A Star Is Born" in HematologyMartin Dreyling, Martina Manni, Massimo Federico
Seminars in Oncology|March 26, 2003
Rituximab plus chemotherapy in follicular and mantle cell lymphomasWolfgang Hiddemann, Martin Dreyling, Michael Unterhalt
Electrophoresis|October 27, 2006
Sample pooling in 2-D gel electrophoresis: a new approach to reduce nonspecific expression backgroundMarc Weinkauf, Wolfgang Hiddemann, Martin Dreyling
Pageof 34

Showing results (31-40 of 336) with videos related to

Sort By:
Pageof 34
Hematological Oncology|June 9, 2021
Mantle cell lymphoma-Advances in molecular biology, prognostication and treatment approachesElisabeth Silkenstedt, Martin Dreyling
Haematologica|February 3, 2016
The role of targeted treatment in mantle cell lymphoma: is transplant dead or alive?Martin Dreyling, Simone Ferrero,
Leukemia & Lymphoma|February 13, 2010
Rituximab in relapsed aggressive lymphoma: play it again, Sam?Martin Dreyling, Christian Schmidt
Drugs|April 8, 2016
The Emerging Role of PI3K Inhibitors in the Treatment of Hematological Malignancies: Preclinical Data and Clinical Progress to DateTill Seiler, Grit Hutter, Martin Dreyling
Cancer Treatment Reviews|June 27, 2017
Mantle cell lymphoma - Current standards of care and future directionsPeter Martin, Paola Ghione, Martin Dreyling
The Lancet. Haematology|December 6, 2016
Time to publish: challenging the performance of cooperative group lymphoma trialsMassimo Federico, Judith Trotman, Martin Dreyling
Cancer|August 27, 2004
The role of fludarabine in the treatment of follicular and mantle cell lymphomaGeorg Lenz, Wolfgang Hiddemann, Martin Dreyling
Hemasphere|March 27, 2023
La Cantera: "A Star Is Born" in HematologyMartin Dreyling, Martina Manni, Massimo Federico
Seminars in Oncology|March 26, 2003
Rituximab plus chemotherapy in follicular and mantle cell lymphomasWolfgang Hiddemann, Martin Dreyling, Michael Unterhalt
Electrophoresis|October 27, 2006
Sample pooling in 2-D gel electrophoresis: a new approach to reduce nonspecific expression backgroundMarc Weinkauf, Wolfgang Hiddemann, Martin Dreyling
Pageof 34